Treatment for pulmonary embolism generally lasts at least six months. Depending on the severity of the condition, a portion of the treatment may require hospitalization. In cases where genetic predispositions such as Protein C deficiency, Factor V Leiden mutation, or Antithrombin III deficiency are present, the patient may need to use anticoagulant medication lifelong.